Courage for simplification and imperfection in the 21st century assessment of "endocrine disruption"

Altex

Volumn 27, Issue 4, 2010, Pages 264-278

  Dietrich, Daniel R ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Combinatorial toxicology; Integrated testing strategies; Risk assessment in humans

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN; DIETHYLSTILBESTROL; ENDOCRINE ACTIVE COMPOUND; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHISTERONE; GLITAZONE DERIVATIVE; HALOGEN; HORMONE; HYDROXYPROGESTERONE; KETOCONAZOLE; MEDROXYPROGESTERONE; METHANDRIOL; METHYLESTRENOLONE; METHYLTESTOSTERONE; NORETHISTERONE; NORETYNODREL; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG; ENDOCRINE DISRUPTOR;

ADVERSE OUTCOME; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CERVICO VAGINAL CANCER; CLEAR CELL CARCINOMA; DOSE RESPONSE; DRUG EXPOSURE; ENDOCRINE DISEASE; ENDOCRINE DISRUPTION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MENARCHE; NONHUMAN; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PROTEIN EXPRESSION; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; UTERINE CERVIX CANCER; VAGINA CANCER; ANIMAL; ANIMAL TESTING ALTERNATIVE; ARTICLE; ECONOMICS; FEMALE; MALE; METHODOLOGY; POLLUTANT; STANDARD;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; RISK ASSESSMENT; TOXICITY TESTS;

EID: 79955706744     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Akahori, Y., Nakai, M., Yamasaki, K. et al. (2008). Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals. Toxicol. In Vitro 22, 225-231. (Pubitemid 350301974)
2. Alonso-Magdalena, P., Vieira, E., Soriano, S. et al. (2010). Bisphenol-A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ. Health Perspect., in press.
3. Block, K., Kardana, A., Igarashi, P. and Taylor, H. S. (2000). In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J. 14, 1101-1108. (Pubitemid 30350391)
4. st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects. Toxicol. Sci. 114, 20-24.
5. Bongiovanni, A. M., Di George, A. M. and Gummbach, M. M. (1959). Masculinization of the female infant assocuated with estrogenic therapy alone during gestation: Four cases. J. Clin. Endocrinol. Metab. 19, 1004-1011.
6. Bongiovanni, A. M. and McPadden, A. J. (1960). Steroids during pregnancy and possible fetal consequences. Fertility and Sterility 11, 181-186.
7. Borrell, B. (2010a). Bisphenol A link to heart disease confirmed. Nature, 7.
8. Borrell, B. (2010b). Toxicology: The big test for bisphenol A. Nature 464, 1122-1124.
9. Bovee, T. F., Lommerse, J. P., Peijnenburg, A. A. et al. (2008). A new highly androgen specific yeast biosensor, enabling optimisation of (Q)SAR model approaches. J. Steroid. Biochem. Mol. Biol. 108, 121-131. (Pubitemid 351173824)
10. Braverman, L. E., Pearce, E. N., He, X. et al. (2006). Effects of six months of daily low-dose perchlorate exposure on thyroid function in healthy volunteers. J. Clin. Endocrinol. Metab. 91, 2721-2724. (Pubitemid 44024643)
11. Breen, M. S., Breen, M., Terasaki, N. et al. (2010). Computational model of steroidogenesis in human H295R cells to predict biochemical response to endocrine-active chemicals: model development for metyrapone. Environ. Health Perspect. 118, 265-272.
12. Bremer, S., Pellizzer, C., Hoffmann, S. et al. (2007). The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. Curr. Pharm. Des. 13, 3047-3058. (Pubitemid 350130970)
13. Burstein, R. and Wasserman, H. C. (1964). The effect of provera on the fetus. Obstet. Gynecol. 23, 931-934.
14. Chapin, R. E., Adams, J., Boekelheide, K. et al. (2008). NTPCERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res. B Dev. Reprod. Toxicol. 83, 157-395. (Pubitemid 352002664)
15. st century. Toxicol. Sci. 112, 17-22.
16. Choi, J. S., Han, J. Y., Ahn, H. K. et al. (2006). Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy. Diabetes Care 29, 2176.
17. Chou, Y. Y., Huang, P. C., Lee, C. C. et al. (2009). Phthalate exposure in girls during early puberty. J. Pediatr. Endocrinol. Metab. 22, 69-77.
18. rd, Andersen, M. E. and Blaauboer, B. J. (2008). On the incorporation of chemical-specific information in risk assessment. Toxicol. Lett. 180, 100-109.
19. Colborn, T. (1994). The wildlife/human connection: modernizing risk decisions. Environ. Health Perspect. 102, Suppl. 12, 55-59.
20. Colborn, T. (1995). Environmental estrogens: health implications for humans and wildlife. Environ. Health Perspect. 103, Suppl. 7, 135-136.
21. Colborn, T., vom Saal, F. S. and Soto, A. M. (1993). Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101, 378-384. (Pubitemid 23343683)
22. Coscrove, M. D., Benton, B. and Henderson, B. E. (1977). Male genitourinary abnormalities and maternal diethylstilbestrol. J. Urol. 117, 220-222. (Pubitemid 8047851)
23. Cunningham, A., Klopman, G. and Rosenkranz, H. S. (1996). The carcinogenicity of diethylstilbestrol: structural evidence for a non-genotoxic mechanism. Arch. Toxicol. 70, 356-361. (Pubitemid 26095131)
24. Dohler, K. D., Wong, C. C. and Von zur Muhlen, A. (1979). The rat as model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol. Ther. B 5, 305-318. (Pubitemid 9225547)
25. Freyberger, A. and Schmuck, G. (2005). Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay. Toxicology Letters 155, 1-13. (Pubitemid 39600731)
26. Freyberger, A., Wilson, V., Weimer, M. et al. (2010a). Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-[alpha] binding assay: Protocol optimization and intralaboratory assay performance as initial steps towards validation. Reproductive Toxicology, in press, corrected proof.
27. Freyberger, A., Witters, H., Weimer, M. et al. (2010b). Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation. Reproductive Toxicology, in press, corrected proof.
28. Gelbke, H.-P., Hofmann, A., Owens, J. and Freyberger, A. (2007). The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration. Archives of Toxicology 81, 227-250. (Pubitemid 46434775)
29. Gill, W. B., Schumacher, G. F., Bibbo, M. et al. (1979). Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J. Urol. 122, 36-39. (Pubitemid 9248408)
30. Giusti, R. M., Iwamoto, K. and Hatch, E. E. (1995). Diethylstilbestrol revisited: a review of the long-term health effects. Ann. Intern. Med. 122, 778-788.
31. Gladek, A. and Liehr, J. G. (1989). Mechanism of genotoxicity of diethylstilbestrol in vivo. J. Biol. Chem. 264, 16847-16852. (Pubitemid 19243585)
32. Goodman, J. E., McConnell, E. E., Sipes, I. G. et al. (2006). An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit. Rev. Toxicol. 36, 387-457.
33. Goodman, J. E., Witorsch, R. J., McConnell, E. E. et al. (2009). Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit. Rev. Toxicol. 39, 1-75.
34. Gray, L. E., Jr., Barlow, N. J., Howdeshell, K. L. et al. (2009). Transgenerational effects of Di (2-Ethylhexyl) phthalate in the male CRL:CD(SD) rat: added value of assessing multiple offspring per litter. Toxicol. Sci. 110, 411-425.
35. Gray, L. E., Jr., Ostby, J., Furr, J. et al. (2000). Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol. Sci. 58, 350-365. (Pubitemid 32042433)
36. Gray, L. E., Jr., Ryan, B., Hotchkiss, A. K. and Crofton, K. M. (2010). Rebuttal of "flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research" by Vom Saal, 2010. Toxicol. Sci., kfq073.
37. Gray, L. E., Jr., Wilson, V. S., Stoker, T. et al. (2006). Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int. J. Androl. 29, 96-104; discussion 105-108.
38. Gray, L. E., Ostby, J., Furr, J. et al. (2001). Effects of environmental antiandrogens on reproductive development in experimental animals. Hum. Reprod. Update 7, 248-264. (Pubitemid 32440287)
39. Greenman, D. L., Dooley, K., Breeden, C. R. and Gass, G. H. (1977). Strain differences in the response of the mouse to diethylstilbestrol. J. Toxicol. Environ. Health 3, 589-597. (Pubitemid 8203940)
40. Guillette, L. J., Jr., Gross, T. S., Gross, D. A. et al. (1995). Gonadal steroidogenesis in vitro from juvenile alligators obtained from contaminated or control lakes. Environ. Health Perspect. 103, Suppl. 4, 31-36.
41. Guillette, L. J., Jr., Gross, T. S., Masson, G. R. et al. (1994). Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ. Health Perspect. 102, 680-688. (Pubitemid 24276619)
42. Guillette, L. J., Jr. and Guillette, E. A. (1996). Environmental contaminants and reproductive abnormalities in wildlife: implications for public health? Toxicol. Ind. Health 12, 537-550.
43. Haddad, G. F., Jodicke, C., Thomas, M. A. et al. (2008). Case series of rosiglitazone used during the first trimester of pregnancy. Reprod. Toxicol. 26, 183-184.
44. Hallmark, N., Walker, M., McKinnell, C. et al. (2007). Effects of monobutyl and di(n-butyl) phthalate in vitro on steroidogenesis and Leydig cell aggregation in fetal testis explants from the rat: comparison with effects in vivo in the fetal rat and neonatal marmoset and in vitro in the human. Environ. Health Perspect. 115, 390-396. (Pubitemid 46554437)
45. Hartung, T. (2009). Toxicology for the twenty-first century. Nature 460, 208-212.
46. st century? ALTEX, current issue.
47. Hartung, T., and Daston, G. (2009). Are in vitro tests suitable for regulatory use? Toxicol. Sci. 111, 233-237.
48. Hecker, M., Hollert, H., Cooper, R. et al. (2007). The OECD validation program of the H295R steroidogenesis assay for the identification of In vitro inhibitors and inducers of testosterone and estradiol production. Phase 2: Inter-laboratory pre-validation studies. Environmental Science and Pollution Research 14, 23-30. (Pubitemid 46732437)
49. Hodgert Jury, H., Zacharewski, T. R. and Hammond, G. L. (2000). Interactions between human plasma sex hormone-binding globulin and xenobiotic ligands. J. Steroid Biochem. Mol. Biol. 75, 167-176. (Pubitemid 32169679)
50. Huang, P. C., Kuo, P. L., Chou, Y. Y. et al. (2009). Association between prenatal exposure to phthalates and the health of newborns. Environ. Int. 35, 14-20.
51. Ishizuka, N. (1962). [Masculinizing effect of anabolic steroids in female newborn children]. Sanfujinka No Shinpo 14, 327-328.
52. Ishizuka, N., Kawashima, Y., Nakanishi, T. et al. (1962). Statistical observations on genital anomalities of newborns following the administration of progestins to their mothers. Journal of the Japanese Obstetrician and Gynecological Society 9, 271.
53. Jacobs, M. N., Janssens, W., Bernauer, U. et al. (2008). The use of metabolising systems for in vitro testing of endocrine disruptors. Curr. Drug Metab. 9, 796-826.
54. Jacobson, B. D. (1962). Hazards of norethindrone therapy during pregancy. Am. J. Obstet. Gynecol. s84, 962-968.
55. Jefferies, J. A., Robboy, S. J., O'Brien, P. C. et al. (1984). Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am. J.Obstet. Gynecol. 148, 59-66. (Pubitemid 14218547)
56. Judson, R. S., Houck, K. A., Kavlock, R. J. et al. (2009). In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 118.
57. Kalyoncu, N. I., Yaris, F., Ulku, C. et al. (2005). A case of rosiglitazone exposure in the second trimester of pregnancy. Reprod. Toxicol. 19, 563-564. (Pubitemid 40313613)
58. Kaplan, N. M. (1959). Male pseudohermaphrodism: report of a case, with observations on pathogenesis. N. Engl. J. Med. 261, 641-644.
59. Klimisch, H. J., Andreae, M. and Tillmann, U. (1997). A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 25, 1-5. (Pubitemid 27117571)
60. Klip, H., Verloop, J., van Gool, J. D. et al. (2002). Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 359, 1102-1107. (Pubitemid 34270733)
61. Kuiper, G. G. J. M., Carlsson, B., Grandien, K. et al. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870. (Pubitemid 27089735)
62. Lang, I. A., Galloway, T. S., Scarlett, A. et al. (2008). Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300, 1303-1310.
63. Lin, Q., Poon, S. L., Chen, J. et al. (2009). Leptin interferes with 3′,5′-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells. Reprod. Biol. Endocrinol. 7, 115.
64. Luu-The, V. and Labrie, F. (2010). The intracrine sex steroid biosynthesis pathways. Prog. Brain Res. 181, 177-192.
65. Lynch, B. S., Tischler, A. S., Capen, C. et al. (1996). Low digestible carbohydrates (polyols and lactose): significance of adrenal medullary proliferative lesions in the rat. Regul. Toxicol. Pharmacol. 23, 256-297. (Pubitemid 26308983)
66. Ma, L. (2009). Endocrine disruptors in female reproductive tract development and carcinogenesis. Trends in Endocrinology & Metabolism 20, 357-363.
67. Matthews, J. B., Twomey, K. and Zacharewski, T. R. (2001). In vitro and in vivo interactions of Bisphenol A and its metabolite, Bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 14, 149-157. (Pubitemid 32173316)
68. McClain, R. M. (1995). Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutat. Res. 333, 131-142.
69. Meeker, J. D., Calafat, A. M. and Hauser, R. (2009). Urinary Bisphenol A concentrations in relation to serum Thyroid and reproductive hormone levels in men from an infertility clinic. Environ. Sci. Technol. 44, 1458-1463.
70. Melzer, D., Rice, N. E., Lewis, C. et al. (2010). Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 5, e8673.
71. Mittendorf, R. (1995). Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology 51, 435-445.
72. Myers, J. P., vom Saal, F. S., Akingbemi, B. T. et al. (2009).Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ. Health Perspect. 117, 309-315.
73. Nagao, T., Saito, Y., Usumi, K. et al. (2002). Low-dose bisphenol A does not affect reproductive organs in estrogen-sensitive C57BL/6N mice exposed at the sexually mature, juvenile, or embryonic stage. Reprod. Toxicol. 16, 123-130. (Pubitemid 34457184)
74. Neill, J. D., Plant, T. M., Pfaff, D. W. et al. (Eds.) (2006a). Knobil and Neill's Physiology of Reproduction (Third Edition, Vol. 1). New York: Elsevier B.V.
75. Neill, J. D., Plant, T. M., Pfaff, D. W. et al. (Eds.) (2006b). Knobil and Neill's Physiology of Reproduction (Third Edition, Vol. 2). New York: Elsevier B.V.
76. NRC (2000). National Research Council: Scientific frontiers in developmental toxicology and risk assessment. Washington DC: National Academy Press.
77. O'Brien, P. C., Noller, K. L., Robboy, S. J. et al. (1979). Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet. Gynecol. 53, 300-308. (Pubitemid 9110952)
78. Palmer, J. R., Herbst, A. L., Noller, K. L. et al. (2009). Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ. Health 8, 37.
79. Palmer, J. R., Wise, L. A., Robboy, S. J. et al. (2005). Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology 16, 583-586. (Pubitemid 40847848)
80. Patel, S. S., Beshay, V. E., Escobar, J. C. et al. (2009). Molecular mechanism for repression of 17alpha-hydroxylase expression and androstenedione production in granulosa cells. J. Clin. Endocrinol. Metab. 94, 5163-5168.
81. Richter, C. A., Birnbaum, L. S., Farabollini, F. et al. (2007). In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24, 199-224. (Pubitemid 47385096)
82. Robboy, S. J., Friedlander, L. M., Welch, W. R. et al. (1976). Cytology of 575 young women with prenatal exposure to diethylstilbestrol. Obstet. Gynecol. 48, 511-515.
83. Robboy, S. J., Noller, K. L., O'Brien, P. et al. (1984). Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol- exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 252, 2979-2983. (Pubitemid 15210470)
84. Root, A. W. and Diamond, F. B. (2007). Overgrowth syndromes: evaluation and management of the child with excessive linear growth. In F. Lifshitz (ed.), Pediatric Endocrinology (163-194). New York: Informa Health Care.
85. Rosenbloom, A. L. (2008). The physiology of human growth: a review. Review of Endocrinology, 36-48.
86. Rouiller-Fabre, V., Muczynski, V., Lambrot, R. et al. (2009). Ontogenesis of testicular function in humans. Folia Histochem. Cytobiol. 47, S19-24.
87. st Century. Environ. Health Perspect. 118(8), 1047-1050.
88. Ryan, B. C., Hotchkiss, A. K., Crofton, K. M. and Gray, L. E., Jr. (2010a). In utero and lactational exposure to Bisphenol A, in contrast to Ethinyl Estradiol, does not alter sexually dimorphic behavior, puberty, fertility, and anatomy of female LE rats. Toxicol. Sci. 114, 133-148.
89. Ryan, K. K., Haller, A. M., Sorrell, J. E. et al. (2010b). Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology, en.2009-1218.
90. Safe, S. (1993). Male sexual development in "a sea of oestrogen". Lancet 342, 125.
91. Schardein, J. (1980). Congenital abnormalities and hormones during preganacy: a clinical review. Teratology 22, 251-270.
92. Schneider, K., Schwarz, M., Burkholder, I. et al. (2009). "ToxR-Tool", a new tool to assess the reliability of toxicological data. Toxicol. Lett. 189, 138-144.
93. Schteingart, D. E. (2009). Drugs in the medical treatment of Cushing's syndrome. Expert Opin. Emerg. Drugs 14, 661-671.
94. Scott, H. M., Mason, J. I. and Sharpe, R. M. (2009). Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr. Rev. 30, 883-925.
95. Seiler, A., Visan, A., Buesen, R. et al. (2004). Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol. 18, 231-240. (Pubitemid 38333047)
96. Sena, E. S., van der Worp, H. B., Bath, P. M. W. et al. (2010). Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol. 8, e1000344.
97. Shanks, N., Greek, R. and Greek, J. (2009). Are animal models predictive for humans? Philos. Ethics Humanit. Med. 4, 2.
98. Sharpe, R. M. (2010). Is it time to end concerns over the estrogenic effects of bisphenol A? Toxicol. Sci. 114, 1-4.
99. Sharpe, R. M., Fisher, J. S., Millar, M. M. et al. (1995). Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect. 103, 1136-1143. (Pubitemid 26141419)
100. Sharpe, R. M. and Skakkebaek, N. E. (1993). Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392-1395. (Pubitemid 23159997)
101. Sharpe, R. M. and Skakkebaek, N. E. (2008). Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 89, e33-38. (Pubitemid 351749385)
102. stcentury. Trends Pharmacol. Sc. 22, 281-285.
103. Somm, E., Schwitzgebel, V. M., Toulotte, A. et al. (2009). Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 117, 1549-1555.
104. Song, R., He, Y., Murphy, M. B. et al. (2008). Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line. Chemosphere 71, 1888-1894.
105. Spielmann, H. and Vogel, R. (2008). The extended 1-generation study (OECD 415), as a replacement of the mammalian 2-generation study (OECD 416). AATEX 14, 795-798.
106. Sumpter, J. P. (1995). Feminized responses in fish to environmental estrogens. Toxicol. Lett. 82-83, 737-742.
107. Sumpter, J. P. (1998a). Reproductive effects from oestrogen activity in polluted water. Arch. Toxicol., Suppl. 20, 143-150.
108. Sumpter, J. P. (1998b). Xenoendorine disrupters - environmental impacts. Toxicol. Lett. 102-103, 337-342.
109. Sumpter, J. P. and Jobling, S. (1995). Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ. Health Perspect. 103, Suppl 7, 173-178.
110. Swan, S. H. (2000). Intrauterine exposure to diethylstilbestrol: long-term effects in humans. Apmis 108, 793-804.
111. Swenberg, J. A., Dietrich, D. R., McClain, R. M. and Cohen, S. M. (1992). Species-specific mechanisms of carcinogenesis. IARC Sci. Publ., 477-500.
112. Takayama, S., Aihara, K., Onodera, T. and Akimoto, T. (1986). Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys. Toxicol. Appl. Pharmacol. 82, 191-199. (Pubitemid 16148068)
113. Tan, S. W., Timm, G. E. and Amcoff, P. (2007). History and genesis of the detailed review of thyroid hormone disruption assays. Crit. Rev. Toxicol. 37, 1-4.
114. Taxvig, C., Elleby, A., Sonne-Hansen, K. et al. (2010). Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, aromatase, estrogen, and androgen activity. Nutr. Cancer 62, 122-131.
115. Tyl, R. W., Myers, C. B., Marr, M. C. et al. (2008). Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 104, 362-384. (Pubitemid 352038259)
116. Vandenberg, L. N., Chauhoud, I., Padmanabhan, V. et al. (2010). Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ. Health Perspect., in press.
117. Veurink, M., Koster, M. and Berg, L. T. (2005). The history of DES, lessons to be learned. Pharm. World Sci. s, 139-143.
118. vom Saal, F. S., Akingbemi, B. T., Belcher, S. M. et al. (2007). Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 24, 131-138. (Pubitemid 47385099)
119. Wajner, S. M., Wagner, M. S. and Maia, A. L. (2009). Clinical implications of altered thyroid status in male testicular function. Arq. Bras. Endocrinol. Metabol. 53, 976-982.
120. Whitehead, E. D. and Leiter, E. (1981). Genital abnormalities and abnormal semen analyses in male patients exposed to diethylstilbestrol in utero. J. Urol. 125, 47-50. (Pubitemid 11155869)
121. Whitelaw, M. J., Nola, V. F. and Kalman, C. F. (1966). Irregular menses, amenorrhea, and infertility following synthetic progestational agents. JAMA 195, 780-782.
122. Willhite, C. C., Ball, G. L. and McLellan, C. J. (2008). Derivation of a bisphenol A oral reference dose (RfD) and drinkingwater equivalent concentration. J. Toxicol. Environ. Health B Crit. Rev. 11, 69-146.
123. Witters, H., Freyberger, A., Smits, K. et al. (2010). The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: Results of test performance and transferability. Reprod. Toxicol., in press, uncorrected proof.
124. Yaris, F., Yaris, E., Kadioglu, M. et al. (2004). Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod. Toxicol. 18, 619-621. (Pubitemid 38609293)